Associate, Goldman Ismail Tomaselli Brennan & Baum LLP
Associate, Sidley Austin, LLP
The University of Chicago Law School (J.D., with honors)
- Kirkland & Ellis Scholar (for grades in top 5% of class)
- Sidley Austin Prize for Excellence in Brief Writing
- The University of Chicago Law Review, Member
The University of Chicago (B.A.)
- Departmental Honors
- Dean’s List
Bar & Court Admissions
State of Illinois
U.S. District Court, Northern District of Illinois
Laura A. Sexton
Laura has a range of experience representing major corporations in commercial litigation and products liability litigation. A talented and accomplished brief writer, Laura has won multiple victories on dispositive motions and excels at translating complex concepts into simple and compelling narratives. She effectively manages all aspects of complex litigation, from large-scale discovery to taking depositions and preparing fact and expert witnesses to trial work.
Laura has also successfully represented several clients in pro bono matters, including a victory in an immigration matter that prevented the deportation of her client. She is also active in the Chicago legal community and serves on the Associate Board of the Legal Aid Society.
- Selected by Super Lawyers as an Illinois Rising Star (2018, 2019)
- Federal Bar Association, Chicago Chapter, Award for Excellence in Pro Bono Service (2017)
Ethicon, Inc. and Johnson & Johnson Pelvic Repair System Litigation
Represents Ethicon, Inc. and Johnson & Johnson in federal litigation involving pelvic mesh products.
In re K-Dur Antitrust Litigation
Represented Merck in the class action and consolidated opt-out antitrust lawsuits brought by wholesalers and major pharmacy retail chains that directly purchased K-Dur® 20, an extended-release potassium chloride supplement. Plaintiffs claimed that a June 1997 patent settlement with a generic maker of K-Dur® 20 was anticompetitive. The matter settled shortly before trial.
In re Mirena IUD Products Liability Litigation
Represents Bayer in federal and state litigation involving Mirena® intrauterine device.
The 'Natural' Cases: An Update After FDA's Request for Comments, Natural Products INSIDER (February 3, 2016)
Cosmeceuticals: The Next Wave of Class-Action Litigation, InsideCounsel (July 15, 2015)
Beware of "Subject To and Not Waiving" in Discovery Responses, American Bar Association, Products Liability, News & Developments (May 21, 2015)
Federal Preemption of Food Labeling Claims, BNA's Product Safety & Liability Reporter (January 12, 2015)
Supreme Court Allows Lanham Act Challenges to Food Labels, American Bar Association, Products Liability, News & Developments (July 7, 2014)